These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

370 related items for PubMed ID: 26517877

  • 1. Pilot Field Trial of the EG95 Vaccine Against Ovine Cystic Echinococcosis in Rio Negro, Argentina: Second Study of Impact.
    Larrieu E, Mujica G, Gauci CG, Vizcaychipi K, Seleiman M, Herrero E, Labanchi JL, Araya D, Sepúlveda L, Grizmado C, Calabro A, Talmon G, Poggio TV, Crowley P, Cespedes G, Santillán G, García Cachau M, Lamberti R, Gino L, Donadeu M, Lightowlers MW.
    PLoS Negl Trop Dis; 2015; 9(10):e0004134. PubMed ID: 26517877
    [Abstract] [Full Text] [Related]

  • 2. Pilot field trial of the EG95 vaccine against ovine cystic echinococcosis in Rio Negro, Argentina: 8 years of work.
    Larrieu E, Mujica G, Araya D, Labanchi JL, Arezo M, Herrero E, Santillán G, Vizcaychipi K, Uchiumi L, Salvitti JC, Grizmado C, Calabro A, Talmon G, Sepulveda L, Galvan JM, Cabrera M, Seleiman M, Crowley P, Cespedes G, García Cachau M, Gino L, Molina L, Daffner J, Gauci CG, Donadeu M, Lightowlers MW.
    Acta Trop; 2019 Mar; 191():1-7. PubMed ID: 30576624
    [Abstract] [Full Text] [Related]

  • 3. Pilot field trial of the EG95 vaccine against ovine cystic echinococcosis in Rio Negro, Argentina: early impact and preliminary data.
    Larrieu E, Herrero E, Mujica G, Labanchi JL, Araya D, Grizmado C, Calabro A, Talmon G, Ruesta G, Perez A, Gatti A, Santillán G, Cabrera M, Arezzo M, Seleiman M, Cavagión L, Cachau MG, Alvarez Rojas CA, Gino L, Gauci CG, Heath DD, Lamberti R, Lightowlers MW.
    Acta Trop; 2013 Aug; 127(2):143-51. PubMed ID: 23632258
    [Abstract] [Full Text] [Related]

  • 4. Analysis of vaccination strategy against cystic echinococcosis developed in the Province of Río Negro, Argentina: 12 years of work.
    Labanchi JL, Poggio TV, Gutiérrez A, Mujica G, Araya D, Grizmado C, Calabro A, Crowley P, Arezo M, Seleiman M, Herrero E, Sepulveda L, Talmon G, Diaz O, Larrieu E.
    Vet Parasitol; 2022 Oct; 310():109790. PubMed ID: 36054969
    [Abstract] [Full Text] [Related]

  • 5. Pilot field trial of the EG95 vaccine against ovine cystic echinococcosis in Rio Negro, Argentina: Humoral response to the vaccine.
    Larrieu E, Poggio TV, Mujica G, Gauci CG, Labanchi JL, Herrero E, Araya D, Grizmado C, Calabro A, Talmon G, Crowley P, Santillán G, Vizcaychipi K, Seleiman M, Sepulveda L, Arezo M, Cachau MG, Lamberti R, Molina L, Gino L, Donadeu M, Lightowlers MW.
    Parasitol Int; 2017 Jun; 66(3):258-261. PubMed ID: 28167154
    [No Abstract] [Full Text] [Related]

  • 6. Control of cystic echinococcosis in the Middle Atlas, Morocco: Field evaluation of the EG95 vaccine in sheep and cesticide treatment in dogs.
    Amarir F, Rhalem A, Sadak A, Raes M, Oukessou M, Saadi A, Bouslikhane M, Gauci CG, Lightowlers MW, Kirschvink N, Marcotty T.
    PLoS Negl Trop Dis; 2021 Mar; 15(3):e0009253. PubMed ID: 33684115
    [Abstract] [Full Text] [Related]

  • 7. Preliminary evaluation of a thermosensitive chitosan hydrogel for Echinococcus granulosus vaccine delivery.
    Umair S, Pernthaner A, Deng Q, Gibson B, Hook S, Heath D.
    Vet Parasitol; 2017 Mar 15; 236():117-120. PubMed ID: 28288754
    [Abstract] [Full Text] [Related]

  • 8. Immunological responses and potency of the EG95NC- recombinant sheep vaccine against cystic echinococcosis.
    Jazouli M, Lightowlers MW, Bamouh Z, Gauci CG, Tadlaoui K, Ennaji MM, Elharrak M.
    Parasitol Int; 2020 Oct 15; 78():102149. PubMed ID: 32464256
    [Abstract] [Full Text] [Related]

  • 9. Serology and longevity of immunity against Echinococcus granulosus in sheep and llama induced by an oil-based EG95 vaccine.
    Poggio TV, Jensen O, Mossello M, Iriarte J, Avila HG, Gertiser ML, Serafino JJ, Romero S, Echenique MA, Dominguez DE, Barrios JR, Heath D.
    Parasite Immunol; 2016 Aug 15; 38(8):496-502. PubMed ID: 27104482
    [Abstract] [Full Text] [Related]

  • 10. Serological monitoring of protection of sheep against Echinococcus granulosus induced by the EG95 vaccine.
    Heath DD, Koolaard J.
    Parasite Immunol; 2012 Jan 15; 34(1):40-4. PubMed ID: 22043983
    [Abstract] [Full Text] [Related]

  • 11. Vaccination of bovines against Echinococcus granulosus (cystic echinococcosis).
    Heath DD, Robinson C, Shakes T, Huang Y, Gulnur T, Shi B, Zhang Z, Anderson GA, Lightowlers MW.
    Vaccine; 2012 Apr 26; 30(20):3076-81. PubMed ID: 22406459
    [Abstract] [Full Text] [Related]

  • 12. Maternal antibody parameters of cattle and calves receiving EG95 vaccine to protect against Echinococcus granulosus.
    Heath DD, Robinson C, Lightowlers MW.
    Vaccine; 2012 Nov 26; 30(50):7321-6. PubMed ID: 22981849
    [Abstract] [Full Text] [Related]

  • 13. Vaccination trials in Australia and Argentina confirm the effectiveness of the EG95 hydatid vaccine in sheep.
    Lightowlers MW, Jensen O, Fernandez E, Iriarte JA, Woollard DJ, Gauci CG, Jenkins DJ, Heath DD.
    Int J Parasitol; 1999 Apr 26; 29(4):531-4. PubMed ID: 10428628
    [Abstract] [Full Text] [Related]

  • 14. Immunity and vaccine control of Echinococcus granulosus infection in animal intermediate hosts.
    Lightowlers MW, Heath DD.
    Parassitologia; 2004 Jun 26; 46(1-2):27-31. PubMed ID: 15305682
    [Abstract] [Full Text] [Related]

  • 15. Antigenic differences between the EG95-related proteins from Echinococcus granulosus G1 and G6 genotypes: implications for vaccination.
    Alvarez Rojas CA, Gauci CG, Lightowlers MW.
    Parasite Immunol; 2013 Feb 26; 35(2):99-102. PubMed ID: 23009356
    [Abstract] [Full Text] [Related]

  • 16. Echinococcus granulosus: variability of the host-protective EG95 vaccine antigen in G6 and G7 genotypic variants.
    Chow C, Gauci CG, Vural G, Jenkins DJ, Heath DD, Rosenzvit MC, Harandi MF, Lightowlers MW.
    Exp Parasitol; 2008 Aug 26; 119(4):499-505. PubMed ID: 18342311
    [Abstract] [Full Text] [Related]

  • 17. Echinococcus granulosus infection and options for control of cystic echinococcosis in Tibetan communities of Western Sichuan Province, China.
    Yang YR, McManus DP, Huang Y, Heath DD.
    PLoS Negl Trop Dis; 2009 Aug 26; 3(4):e426. PubMed ID: 19399162
    [Abstract] [Full Text] [Related]

  • 18. Vaccination with rEGVac elicits immunoprotection against different stages of Echinococcus granulosus life cycle: A pilot study.
    Pourseif MM, Moghaddam G, Nematollahi A, Khordadmehr M, Naghili B, Dehghani J, Omidi Y.
    Acta Trop; 2021 Jun 26; 218():105883. PubMed ID: 33676937
    [Abstract] [Full Text] [Related]

  • 19. Hydatid disease: vaccinology and development of the EG95 recombinant vaccine.
    Gauci C, Heath D, Chow C, Lightowlers MW.
    Expert Rev Vaccines; 2005 Feb 26; 4(1):103-12. PubMed ID: 15757477
    [Abstract] [Full Text] [Related]

  • 20. Efficacy of the EG95 hydatid vaccine in a macropodid host, the tammar wallaby.
    Barnes TS, Hinds LA, Jenkins DJ, Coleman GT, Colebrook AL, Kyngdon CT, Gauci CG, Lightowlers MW.
    Parasitology; 2009 Apr 26; 136(4):461-8. PubMed ID: 19195411
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.